Form 3 Filing - Simon Lim Sze Beng Ownership Update
2026-04-27SEC Filing 3 (0001213900-26-048000)
This filing reports initial beneficial ownership of securities by Simon Lim Sze Beng, Co-Chief Executive Officer of China SXT Pharmaceuticals, Inc. (SXTC). The report, filed on Form 3, indicates that Mr. Beng has no securities owned as of January 20, 2025. The filing was signed on April 27, 2026. Mr. Beng's address is listed in Kuala Lumpur, Malaysia. This filing establishes the baseline ownership for Mr. Beng within the company.
Ticker mentioned:SXTC
Source:Original SEC Document β